Vanda Pharmaceuticals Inc. (VNDA)
8.17
+0.00%
Vanda Pharmaceuticals Inc. (VNDA) is currently trading at $8.17. This represents a gain of 0% from the previous session. With a market capitalization of $0.48B, VNDA is a key component of the Health Care sector. Investors looking to trade VNDA should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade VNDA commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Vanda Pharmaceuticals Inc. (VNDA) shows a bullish trend. Analysts are watching the 0.00 level closely.
Fundamentals
Mkt Cap0.48B
P/E Ratio0.0000
Volume123,261
60-Day Technical Chart
Advanced Charting
Need more indicators for VNDA? Use the world's #1 platform.
Open VNDA on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $8
| Metric |
VNDA +0.00% |
MARA +0.00% |
LUMN +0.00% |
SOUN +0.00% |
|---|---|---|---|---|
| Price | $8.17 | $8.05 | $7.45 | $8.36 |
| Mkt Cap | $0.48B | $3.04B | $7.63B | $3.50B |
| - | View → | View → | View → |
Latest Headlines
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
PR Newswire • Feb 11, 2026
VNDA Stock Soars 40% Overnight After Bysanti Approval: What’s The Next Catalyst And How Much Upside Remains?
Stocktwits • Feb 23, 2026
Vanda Pharma: High Risk, Heavily Discounted - Stock Ahead Of PDUFA This Week (NASDAQ:VNDA)
Seeking Alpha • Feb 19, 2026
What's Going On With Vanda Pharma Stock Tuesday?
Bitget • Feb 24, 2026
US FDA approves Vanda's antipsychotic pill, shares climb
Reuters • Feb 20, 2026
● Gemini Agentic AI Analyst Insight for VNDA
Market Education
- Stocks Pivot - Trending Up Dec 10, 2023
- Making Sense of Money: How Interest Rates, Bonds, and Stocks Affect Your Wallet Feb 21, 2024
- 10 rules of money - Follow this and you are set for life Jul 16, 2023
External Research